ARCHBOLD, Ohio, Aug. 18, 2025 (GLOBE NEWSWIRE) -- F&M Bank (“F&M”), an Archbold, Ohio-based bank owned by Farmers & Merchants Bancorp, Inc. (Nasdaq: FMAO), is inviting the community to put on their detective hats for a high-stakes summer challenge, $5,000 for a lucky hunter and $5,000 for a local charity. The Great Briefcase Hunt kicked off Monday, August 18, 2025, and dares residents across the F&M footprint to follow a series of weekly clues leading to a hidden briefcase in a local park. “It’s time to j ...

Core Viewpoint - Tofutti Brands Inc. reported a decline in net sales and increased competition in the vegan cheese market, leading to a net loss for the recent financial periods [2][4][6]. Financial Performance - For the thirteen weeks ended June 28, 2025, net sales decreased by $254,000, or 11%, to $2,029,000 compared to $2,283,000 for the same period in 2024 [2]. - For the twenty-six weeks ended June 28, 2025, net sales were $3,620,000, a decrease of $875,000, or 19%, from $4,495,000 for the same period in 2024 [4]. - Gross profit for the thirteen weeks ended June 28, 2025, decreased to $618,000 from $667,000 in the prior year, while the gross profit percentage increased slightly to 30% from 29% [3]. - Gross profit for the twenty-six weeks ended June 28, 2025, increased to $1,207,000 from $1,136,000 in the prior year, with a gross profit percentage of 33% compared to 25% [5]. Product Sales - Sales of vegan cheese products decreased to $1,708,000 for the thirteen weeks ended June 28, 2025, down from $1,926,000 in the prior year, attributed to increased competition [2]. - Sales of frozen dessert products also declined to $321,000 for the thirteen weeks ended June 28, 2025, from $357,000 for the same period in 2024 [2]. - For the twenty-six weeks ended June 28, 2025, sales of vegan cheese products decreased to $3,081,000 from $3,735,000, and frozen dessert sales decreased to $539,000 from $700,000 [4]. Losses and Cash Position - The company reported a net loss of $(7,000) or $(0.00) per share for the thirteen weeks ended June 28, 2025, compared to a net loss of $(32,000) or $(0.01) per share for the same period in 2024 [6]. - For the twenty-six weeks ended June 28, 2025, the net loss was $(169,000) or $(0.03) per share, compared to $(335,000) or $(0.06) per share for the same period in 2024 [6]. - As of June 28, 2025, the company had approximately $350,000 in cash and working capital of approximately $2,733,000, down from $462,000 in cash and $2,893,000 in working capital at December 30, 2024 [7]. Company Overview - Tofutti Brands Inc. was founded in 1981 and develops a complete line of plant-based products, including over twenty-five dairy-free foods [8]. - The company serves customers in the United States and twelve other countries, catering to those who are allergic or intolerant to dairy or who wish to maintain a kosher or vegan diet [8].

GeForce NOW Gamescom 2025 The NVIDIA Blackwell architecture is coming to GeForce NOW, marking the cloud gaming platform’s biggest update yet. News Summary: The NVIDIA Blackwell architecture is coming to GeForce NOW in the platform’s biggest update yet, delivering NVIDIA GeForce RTX 5080-class GPUs to the cloud, including NVIDIA DLSS 4 Multi-Frame Generation for streaming up to 5K resolution at 120 frames per second, new AI-powered features and more.The GeForce NOW game library will double to over 4,500 ...

MIRAMAR, Fla., Aug. 18, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between inflammation and age-related diseases, today reported financial results and recent business highlights for its second quarter ended June 30, 2025. On May 15, 2025, the Company closed an equity offering with gross proceeds of $5.0 mill ...

Oslo (Norway), 18 August 2025 – PCI Biotech Holding ASA (PCI Biotech, OSE:PCIB) today announces the discontinuation of development of the photochemical lysis (PCL) technology for viral vector manufacturing. Today’s decision is primarily based on the insufficient progress towards the 2025 goal of demonstrating improved yield in mini benchtop bioreactors. Achieving successful end-to-end results in small bioreactors is a critical risk-reducing milestone for further development. Following the progress reported ...

Vancouver, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA; FRA: UB1) is pleased to announce an expansion of the surface gold skarn system at Brezani and the start of the Phase III drill program at its Viogor-Zanik project, Bosnia and Herzegovina. Highlights The Brezani drillhole BRE23001 located 125 m SSW of the maiden Brezani drillhole intercepted 0.27 g/t Au over 72.3 m including 0.62 g/t Au over 7.5 m. Additionally, two antimony ve ...

Core Insights - Mesa Laboratories, Inc. has successfully executed its financial strategy by repaying $97.5 million of its 1.375% Convertible Senior Notes due August 2025, utilizing funds drawn from its Credit Agreement [1][2] - The company aims to optimize its capital structure and reduce shareholder dilution while supporting long-term growth [2][5] Financial Performance - The company drew $97.0 million under its Amended and Restated Credit Agreement, increasing the total outstanding balance to $108 million [1] - Interest rate on the Credit Facility is currently 7.18% and is expected to decrease with future Federal Funds Rate reductions, with anticipated interest payments of approximately $2.7 million for Q2 FY 2026 [2][3] Debt Management - Mesa's total net leverage ratio was 3.16 as of June 30, 2025, defined as total debt minus unrestricted cash in excess of $10 million compared to trailing 12 months EBITDA [3] - The company made over $7 million in principal payments in Q1 FY 2026 and expects to make approximately $20 million in principal payments for the remaining quarters of FY 2026 [4] Company Overview - Mesa Laboratories, Inc. is a global leader in designing and manufacturing life science tools and quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries [6]

As previously announced, the Annual General Meeting of Shareholders of AUGA group, AB, a company undergoing restructuring (legal entity code 126264360, registered office at Konstitucijos Ave. 21C, Vilnius, hereinafter – the “Company”) is convened on the initiative and decision of the Company’s Board on 29th August 2025 at 10:00 AM (hereinafter – the “Meeting”). The Company also publishes the general voting ballot. Agenda of the Meeting: Consolidated management report of the Company for the year 2024 and ind ...

Jakarta, Indonesia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- NusaTrip Incorporated (“NusaTrip,” “NUTR” or the “Company”), a travel ecosystem with geographical specialization in Southeast Asia and Asia-Pacific, today announced the closing of its previously announced initial public offering of an aggregate 3,750,000 shares of Common Stock (“the Offering”) at a price of $4.00 per share (“the Offering Price”) to the public, for a total of $15.0 million of gross proceeds to the Company, before deducting underwriting di ...

On August 18, 2025, a reconvened meeting of creditors (hereinafter – the Meeting) of the AUGA group, AB under restructuring (legal entity code 126264360, registered office address: Konstitucijos pr. 21C, Vilnius; hereinafter – the Company) took place. Over 73% of all creditors participated in the meeting, therefore a quorum was reached. The absolute majority of votes of all participating creditors - only 5 per cent of all participating creditors voted against - approved the draft restructuring plan of AUGA ...